Advertisement
Screener

MONTAUK RENEWABLES, INC. (MNTK) Spending and interest coverage

MONTAUK RENEWABLES, INC. (MNTK) Spending and interest coverage

  • R&D / revenue · 12 months: Value (m); Formula and calculation Research and development expense / revenue. Period ending 2026-06-30..
  • Stock-based compensation / revenue · 12 months: Value 1.03%; Formula and calculation Share-based compensation / revenue. Period ending 2026-06-30..
  • Interest coverage · 12 months: Value (m); Formula and calculation Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified..

Spending and interest coverage

Overview →

Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.

MetricValueFormula and calculation
R&D / revenue · 12 months(m)Research and development expense / revenue. Period ending 2026-06-30.

Calculation unavailable: missing inputs remain (m).

Stock-based compensation / revenue · 12 months1.03%Share-based compensation / revenue. Period ending 2026-06-30.

$1.96M ÷ $189.10M × 100 ≈ 1.03%

Interest coverage · 12 months(m)Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified.

Calculation unavailable: missing inputs remain (m).

Calculation inputs

InputAmount with unitRaw financial data
Research and development spending(m)
Revenue189.10M USDRevenue from Contract with Customer, Excluding Assessed Tax
Stock-based compensation1.96M USDShare-based Payment Arrangement, Noncash Expense
Operating income1.12M USDOperating Income (Loss)
Interest expense · reported / estimated(m)Interest Expense · Estimated expense assumptions

Latest interest expense basis: (m). Estimated values carry *; expand each history row’s basis for its dated balances and rate assumptions.

Calculated history

Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.

Period endingResearch and development spending (USD)Revenue (USD)Stock-based compensation (USD)Operating income (USD)Interest expense · reported / estimated (USD)R&D / revenueSBC / revenueInterest coverageInterest expense basis
2026-06-30(m)$189.10M$1.96M$1.12M(m)(m)1.03%(m)(m)
2026-03-31(m)$180.21M$3.81M$-1.16M(m)(m)2.11%(m)(m)
2025-12-31(m)$176.38M$4.44M$852.00K(m)(m)2.52%(m)(m)
2025-09-30(m)$160.68M$5.80M$-7.32M(m)(m)3.61%(m)(m)
2025-06-30(m)$181.34M$9.26M$10.94M(m)(m)5.11%(m)(m)
2025-03-31(m)$179.55M$8.99M$14.16M(m)(m)5.01%(m)(m)
2024-12-31(m)$175.74M$9.96M$16.12M(m)(m)5.67%(m)(m)
2024-09-30(m)$194.85M$10.94M$33.41M$6.36M(m)5.61%5.26×Reported
2024-06-30(m)$184.62M$9.16M$27.49M$5.82M(m)4.96%4.72×Reported
2024-03-31(m)$194.54M$8.79M$40.17M$5.24M(m)4.52%7.66×Reported
2023-12-31(m)$174.90M$8.32M$23.64M$5.75M(m)4.76%4.11×Reported
2023-09-30(m)$177.26M$8.45M$24.79M$5.13M(m)4.77%4.83×Reported
2023-06-30(m)$180.26M$8.70M$21.64M$3.88M(m)4.83%5.59×Reported
2023-03-31(m)$195.91M$9.27M$32.05M$3.44M(m)4.73%9.33×Reported
2022-12-31(m)$213.39M$9.84M$44.57M$1.79M(m)4.61%24.87×Reported
2022-09-30(m)$209.48M$10.09M$45.29M$1.20M(m)4.82%37.65×Reported
2022-06-30(m)$190.54M$9.91M$38.39M$1.86M(m)5.20%20.58×Reported
2022-03-31(m)$153.32M$10.15M$13.89M$2.31M(m)6.62%6.00×Reported
2021-12-31(m)$148.13M$22.42M$3.33M$2.93M(m)15.13%1.14×Reported
2021-09-30(m)(m)(m)(m)(m)(m)(m)(m)(m)
2021-06-30(m)(m)(m)(m)(m)(m)(m)(m)(m)
2021-03-31(m)(m)(m)(m)(m)(m)(m)(m)(m)
2020-12-31(m)$100.22M$762.00K$3.58M$4.34M(m)0.76%0.83×Reported
2020-09-30(m)(m)(m)(m)(m)(m)(m)(m)(m)
2020-06-30(m)(m)(m)(m)(m)(m)(m)(m)(m)
2020-03-31(m)(m)(m)(m)(m)(m)(m)(m)(m)
2019-12-31(m)$104.02M$570.00K$11.01M$5.58M(m)0.55%1.97×Reported

(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.

Similar stocks

Stock NameCountryMarket CapPE Ratio
Clean Energy Fuels Corp. (CLNE)United States$0.364B
OPAL Fuels Inc. (OPAL)United States$0.046B5.62
UGI CORP /PA/ (UGI)United States$7.803B11.04
SEMPRA (SRE)United States$50.821B27.56